Posted on September 08, 2021 |
By 340B Matters Dear Secretary Becerra, On August 1 and September 1, Boehringer Ingelheim and Merck respectively began denying 340B discount pricing to safety-net healthcare providers that use contract pharmacies. This is ...
Posted on August 17, 2021 |
By 340B Matters At long last, four top pharmaceutical companies are being sued under federal antitrust law for conspiring to deprive safety-net healthcare providers of lower pricing under the 340B Drug ...
Posted on July 29, 2021 |
By 340B Matters The 340B Drug Discount Program is getting robbed daily by insurers and pharmacy benefit managers. Finally, someone in Washington is doing something about it. A new bill in ...
Posted on July 19, 2021 |
By 340B Matters German drug giant Boehringer Ingelheim has unwisely joined an ignominious group of manufacturers attacking the 340B Drug Discount Program. The result will be even less resources for America’s ...
Posted on July 01, 2021 |
By 340B Matters In the complex drug-pricing marketplace lies a murky underworld of pharmacy benefit managers (PBMs). Ostensibly, these companies negotiate lower drug pricing for insurers and (ideally) patients. They’re also ...